414
Participants
Start Date
April 30, 2005
Study Completion Date
November 30, 2005
Trivalent inactivated influenza vaccine
Standard Dose Influenza Vaccine Fluzone® (15 µg HA / viral strain; 45 µg/0.5 mL dose) will be administered to Arm 1: 200 subjects intramuscularly on day 0.
Trivalent inactivated influenza vaccine
High Dose Influenza Fluzone® Vaccine (60 µg HA / viral strain; 180 µg/0.5 mL dose) will be administered to Arm 2: 200 subjects intramuscularly on Day 0.
University of Maryland Baltimore, Baltimore
Saint Louis University, St Louis
Baylor College of Medicine, Houston
University of Iowa - Vaccine Research & Education Unit, Iowa City
Cincinnati Children's Hospital Medical Center, Cincinnati
National Institute of Allergy and Infectious Diseases (NIAID)
NIH